BCAP31

Chr X

B cell receptor associated protein 31

Also known as: 6C6-AG, BAP31, CDM, DDCH, DELXQ28, DXS1357E, MICRODELXq28

This gene encodes a member of the B-cell receptor associated protein 31 superfamily. The encoded protein is a multi-pass transmembrane protein of the endoplasmic reticulum that is involved in the anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi and in caspase 8-mediated apoptosis. Microdeletions in this gene are associated with contiguous ABCD1/DXS1375E deletion syndrome (CADDS), a neonatal disorder. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome 16. [provided by RefSeq, Jan 2012]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.65
Clinical SummaryBCAP31
🧬
Gene-Disease Validity (ClinGen)
severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome · XLDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.21) despite low pLI — interpret in context.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 86 VUS of 268 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.65LOEUF
pLI 0.434
Z-score 2.29
OE 0.21 (0.080.65)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.30Z-score
OE missense 0.67 (0.560.80)
82 obs / 122.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.21 (0.080.65)
00.351.4
Missense OE?0.67 (0.560.80)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 2 / 9.7Missense obs/exp: 82 / 122.5Syn Z: 0.14
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveBCAP31-related deafness, dystonia, and central hypomyelination with disorganization of the Golgi apparatusLOFXLR

This gene — mechanism propensity

DN
0.7326th %ile
GOF
0.5857th %ile
LOF
0.3355th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF76% of P/LP variants are LoF · ClinGen HI: Sufficient evidence for dosage pathogenicity
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

268 submitted variants in ClinVar

Classification Summary

Pathogenic12
Likely Pathogenic5
VUS86
Likely Benign89
Benign25
Conflicting10
12
Pathogenic
5
Likely Pathogenic
86
VUS
89
Likely Benign
25
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
9
0
3
0
12
Likely Pathogenic
4
1
0
0
5
VUS
2
73
10
1
86
Likely Benign
1
7
42
39
89
Benign
2
1
19
3
25
Conflicting
10
Total18827443227

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

134 pathogenic / likely-pathogenic (of 156) ClinVar copy-number / structural variants overlap BCAP31 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

BCAP31 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →